- Pharmaceutical companies
- Jazz Pharmaceuticals
Jazz Pharmaceuticals
Phone: +353353.1.634.7800
E-mail: corporateaffairsmediainfo@jazzpharma.com
Web: https://www.jazzpharma.com
Type | Public company |
---|---|
Traded as |
|
Industry | Biotechnology Pharmaceutical |
Predecessor | Jazz Pharmaceuticals, Inc. (before the 2012 tax inversion to Ireland) |
Founded | March 2005 (2005-03) in California, U.S. |
Headquarters | Waterloo Exchange, Waterloo Road, D04 E5W7, Dublin, Ireland |
Area served | Worldwide |
Key people | Bruce C. Cozadd (Chairman & CEO) |
Products | Pharmaceutical drugs |
Brands |
|
Revenue | US$1.618 billion (2017) |
Operating income | US$528.8 million (2017) |
Net income | US$487.8 million (2017) |
Total assets | US$5.123 billion (2017) |
Total equity | US$2.713 billion (2017) |
Number of employees | ~1,210 (February 2018) |
Website | jazzpharma.com |
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients. We are focused on developing life-changing medicines for people with serious diseases — often with limited or no options — so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Through continued investment in an evolving and growing research and development focus, we seek solutions for rare or complex diseases, and ensure those solutions are available for the often-overlooked patients who need them. Our approach has allowed us to shepherd new medicines to market – from late-stage discovery through clinical development and regulatory approval. All of these advancements are a reflection of our continued investment in an evolving and growing research and development focus.
For detailed contact information visit location pages below.
Jazz Pharmaceuticals's locations around the world
Clinical Trials sponsored by Jazz Pharmaceuticals
-
Jazz PharmaceuticalsRekrutteringTuberøs sklerose kompleks associeret neuropsykiatrisk sygdomForenede Stater, Det Forenede Kongerige, Polen
-
Jazz PharmaceuticalsRekrutteringParkinsons sygdom | RystenForenede Stater, Spanien, Tyskland, Polen
-
Jazz PharmaceuticalsRekrutteringSolid tumor | Metastatisk kræft | Avanceret kræftForenede Stater
-
Jazz PharmaceuticalsRekrutteringTuberøs sklerosekompleks | Dravet syndrom | Lennox Gastaut syndromForenede Stater
-
Jazz PharmaceuticalsRekruttering
-
Jazz PharmaceuticalsAktiv, ikke rekrutterendeHER2-udtrykkende gastrointestinale kræftformer, herunder gastroøsofagealt adenokarcinom, galdevejskræft og kolorektal kræftForenede Stater, Korea, Republikken, Chile, Canada
-
Jazz PharmaceuticalsAktiv, ikke rekrutterendeHER2-udtrykkende cancerForenede Stater, Canada, Korea, Republikken
-
Jazz PharmaceuticalsAfsluttetLurbinectedin monoterapi hos deltagere med avancerede eller metastatiske solide tumorer (EMERGE-201)Avanceret solid tumor | Metastatisk fast tumor | Urothelial kræft | Dårligt differentierede neuroendokrine karcinomer | Homolog rekombination mangelfuld-positive maligniteter AgnostiskForenede Stater
-
Jazz PharmaceuticalsAfsluttetSpasticitet med multipel skleroseSpanien, Forenede Stater, Det Forenede Kongerige, Tjekkiet, Polen
-
Jazz PharmaceuticalsAktiv, ikke rekrutterende